Financial Instruments and Long-Term Investments | 3 Months Ended |
Mar. 31, 2015 |
Investments Debt And Equity Securities [Abstract] | |
Financial Instruments and Long-Term Investments | 2. Financial Instruments and Long-Term Investments: |
Fair Value of Financial Instruments |
The Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) 820 “Fair Value Measurement” (“ASC 820”) defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, not adjusted for transaction costs. ASC 820 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3) as described below: |
|
Level 1 Inputs | — | Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible by the Company; | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Level 2 Inputs | — | Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly or indirectly; | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Level 3 Inputs | — | Unobservable inputs for the asset or liability, including significant assumptions of the Company and other market participants. | | | | | | | | | | | | | | |
The Company determines fair values for the following assets and liabilities: |
Equity securities, listed options and warrants—The Company classifies marketable equity securities and listed options within Level 1 of the fair value hierarchy because quoted market prices from an exchange are used to value these securities. Non-public equity securities, which primarily include securities where the Company acted as a placement agent in an offering of equity securities and where the Company facilitates over-the-counter trading activity for the securities, are classified within Level 3 of the fair value hierarchy. In determining the fair value of these securities, the Company considers enterprise value and analyzes various financial, performance and market factors to estimate the value, including where applicable, over-the-counter market trading activity. Non-exchange traded warrants to purchase equity securities are classified as Level 3 as a Black-Scholes valuation model is used to value these securities. |
U.S. government securities, convertible and fixed income debt instruments—The Company classifies U.S. government securities, including highly liquid U.S. Treasury securities within Level 1 as quoted prices are used to value these securities. Convertible and fixed income debt instruments are classified within Level 2 of the fair value hierarchy as they are valued using quoted market prices provided by a broker or dealer, or alternative pricing services that provide reasonable levels of price transparency. The Company primarily uses price quotes from one independent broker dealer who makes markets in or is a specialist with expertise in the valuation of these financial instruments. The Company reviews broker or pricing service quotes it receives to assess the reasonableness of the values provided; such reviews include comparison to internal pricing models and, when available, prices observed for recently executed market transactions of comparable size. Based on this assessment, at each reporting date the Company will adjust price quotes it receives if such an adjustment is determined to be appropriate. |
Investment Funds—The Company invests in proprietary investment funds that are valued at net asset value (“NAV”) determined by the fund administrator. For investments in non-registered investment companies (hedge funds and private equity funds), the Company classifies these investments within Level 2 or Level 3 depending on the redemption attributes of the Company’s investment. The underlying securities held by these investment companies are primarily corporate and asset-backed fixed income securities and restrictions exist on the redemption of amounts invested by the Company. As a practical expedient, the Company relies on the NAV of these investments as their fair value. The NAVs that have been provided by the fund administrators are derived from the fair values of the underlying investments as of the reporting date. |
Fair Value Hierarchy |
The following tables set forth, by level within the fair value hierarchy, financial instruments and long-term investments accounted for under ASC 820 as of March 31, 2015 and December 31, 2014. As required by ASC 820, assets and liabilities that are measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. |
Items Measured at Fair Value on a Recurring Basis |
|
| March 31, 2015 | | | Level 1 | | | Level 2 | | | Level 3 | | |
Financial instruments owned, at fair value: | | | | | | | | | | | | | | | | |
Financial instruments held for trading activities at | | | | | | | | | | | | | | | | |
broker-dealer subsidiary: | |
Marketable and non-public equity securities | $ | 12,556 | | | $ | 12,511 | | | $ | — | | | $ | 45 | | |
Convertible and fixed income debt instruments | | 32,076 | | | | — | | | | 32,076 | | | | — | | |
| $ | 44,632 | | | $ | 12,511 | | | $ | 32,076 | | | $ | 45 | | |
Financial instruments held for investment activities: | | | | | | | | | | | | | | | | |
Designated as trading: | | | | | | | | | | | | | | | | |
Marketable and non-public equity securities | | 2,208 | | | | — | | | | — | | | | 2,208 | | |
Warrants | | 603 | | | | — | | | | — | | | | 603 | | |
| | 2,811 | | | | — | | | | — | | | | 2,811 | | |
Investment funds | | 101,602 | | | | — | | | | 50,674 | | | | 50,928 | | |
Total | $ | 149,045 | | | $ | 12,511 | | | $ | 82,750 | | | $ | 53,784 | | |
Securities sold but not yet purchased, at fair value: | | | | | | | | | | | | | | | | |
U.S. Treasury securities | $ | 294,397 | | | $ | 294,397 | | | $ | — | | | $ | — | | |
Marketable and non-public equity securities | | 21,119 | | | | 21,119 | | | | | | | | | | |
Convertible and fixed income debt instruments | | 14,249 | | | | — | | | | 14,249 | | | | — | | |
Total | $ | 329,765 | | | $ | 315,516 | | | $ | 14,249 | | | $ | — | | |
|
As of March 31, 2015, financial assets measured and reported at fair value on a recurring basis and classified within Level 3 were $53,784 or 4.0% of the Company’s total assets at that date. Regarding these Level 3 financial assets, in determining fair value, the Company analyzes various financial, performance and market factors to estimate the value, including where applicable, over-the-counter market trading activity. The following table provides the valuation technique and unobservable inputs primarily used in assessing the value of these securities as of March 31, 2015: |
|
|
Valuation Technique | | Fair Value | | | Unobservable Input | | Range | | | Weighted Average | | | |
Market approach | | $ | 2,253 | | | Over-the-counter trading activity | | $ 0 - $17.00/share | | | $15.00 | | | |
Black-Scholes | | $ | 603 | | | Volatility | | 30% | | | | 30% | | | |
| | | | | | Dividend Yield | | 0% | | | | 0% | | | |
| | | | | | Interest Rate | | | 1.80% | | | | 1.80% | | | |
|
For those non-public equity securities valued using a market approach, adverse industry market conditions or events experienced by the underlying entities could result in lower over-the-counter trading prices for the securities. Such lower trading prices would result in a decline in the estimated fair value of these assets. For warrants valued using Black-Scholes, adverse industry market conditions or events experienced by the issuer could result in a lower trading price for the underlying equity security and therefore a lower value of these warrants. A reduction in the estimated volatility would also result in a lower value of the warrants. The Company assessed the reasonableness of the fair values of the non-public equity securities noted above based on its consideration of available financial data related to these issuers as well as an assessment of the nature of any over-the-counter trading activity during the period. The Company assessed the reasonableness of the fair value of the non-exchange traded warrants valued using a Black-Scholes valuation based on its consideration of the fair values of comparable exchange-traded options. |
The table above excludes $50,928 of investments in 11 non-registered investment funds that are valued at NAV as determined by the fund administrators. The underlying fund investments consist primarily of corporate and asset-backed fixed income securities. Considering the general lack of transparency necessary to conduct an independent assessment of the fair value of the securities underlying each of the NAVs provided by the fund administrators, our quarterly reporting process includes a number of assessment processes to assist the Company in the evaluation of the information provided by fund managers and fund administrators. These assessment processes include, but are not limited to regular review and discussion of each fund’s performance with its manager and regular evaluation of performance against applicable benchmarks. |
|
|
| 31-Dec-14 | | | Level 1 | | | Level 2 | | | Level 3 | | |
Financial instruments owned, at fair value: | | | | | | | | | | | | | | | | |
Financial instruments held for trading activities at | | | | | | | | | | | | | | | | |
broker-dealer subsidiary: | |
Marketable and non-public equity securities | $ | 14,832 | | | $ | 14,758 | | | $ | — | | | $ | 74 | | |
Listed options | | 2 | | | | 2 | | | | — | | | | — | | |
Convertible and fixed income debt instruments | | 42,864 | | | | — | | | | 42,864 | | | | — | | |
| | 57,698 | | | | 14,760 | | | | 42,864 | | | | 74 | | |
Financial instruments held for investment activities: | | | | | | | | | | | | | | | | |
Designated as trading: | | | | | | | | | | | | | | | | |
Marketable and non-public equity securities | | 2,325 | | | | 175 | | | | — | | | | 2,150 | | |
Warrants | | 964 | | | | — | | | | — | | | | 964 | | |
Designated as available-for-sale: | | | | | | | | | | | | | | | | |
Marketable equity securities | | 172 | | | | 172 | | | | — | | | | — | | |
| | 3,461 | | | | 347 | | | | — | | | | 3,114 | | |
Investment funds | | 104,888 | | | | — | | | | 58,292 | | | | 46,596 | | |
Total | $ | 166,047 | | | $ | 15,107 | | | $ | 101,156 | | | $ | 49,784 | | |
Securities sold but not yet purchased, at fair value: | | | | | | | | | | | | | | | | |
U.S. Treasury securities | $ | 84,950 | | | $ | 84,950 | | | $ | — | | | $ | — | | |
Marketable and non-public equity securities | | 34,043 | | | | 34,043 | | | | — | | | | — | | |
Convertible and fixed income debt instruments | | 2,317 | | | | — | | | | 2,317 | | | | — | | |
Total | $ | 121,310 | | | $ | 118,993 | | | $ | 2,317 | | | $ | — | | |
|
As of December 31, 2014, financial assets measured and reported at fair value on a recurring basis and classified within Level 3 were $49,784 or 4.8% of the Company’s total assets at that date. Regarding these Level 3 financial assets, in determining fair value, the Company analyzes various financial, performance and market factors to estimate the value, including where applicable, over-the-counter market trading activity. The following table provides the valuation technique and unobservable inputs primarily used in assessing the value of these securities as of December 31, 2014: |
|
|
Valuation Technique | | Fair Value | | | Unobservable Input | | Range | | Weighted Average | | | | | |
Market approach | | $ | 2,224 | | | Over-the-counter trading activity | | $0 - $34.00/share | | $11.56 | | | | | |
Black-Scholes | | $ | 964 | | | Volatility | | 30% | | | 30% | | | | | |
| | | | | | Dividend Yield | | 0% | | | 0% | | | | | |
| | | | | | Interest Rate | | 2.10% | | | 2.10% | | | | | |
|
For those non-public equity securities valued using a market approach, adverse industry market conditions or events experienced by the underlying entities could result in lower over-the-counter trading prices for the securities. Such lower trading prices would result in a decline in the estimated fair value of these assets. For warrants valued using Black-Scholes, adverse industry market conditions or events experienced by the issuer could result in a lower trading price for the underlying equity security and therefore a lower value of these warrants. A reduction in the estimated volatility would also result in a lower value of the warrants. The Company assessed the reasonableness of the fair values of the non-public equity securities noted above based on its consideration of available financial data related to these issuers as well as an assessment of the nature of any over-the-counter trading activity during the period. The Company assessed the reasonableness of the fair value of the non-exchange traded warrants valued using a Black-Scholes valuation based on its consideration of the fair values of comparable exchange-traded options. |
The table above excludes $46,596 of investments in 10 non-registered investment funds that are valued at NAV as determined by the fund administrators. The underlying fund investments consist primarily of corporate and asset-backed fixed income securities. Considering the general lack of transparency necessary to conduct an independent assessment of the fair value of the securities underlying each of the NAVs provided by the fund administrators, our reporting process includes a number of assessment processes to assist the Company in the evaluation of the information provided by fund managers and fund administrators. These assessment processes include, but are not limited to regular review and discussion of each fund’s performance with its manager and regular evaluation of performance against applicable benchmarks. |
Level 3 Gains and Losses |
The tables below set forth a summary of changes in the fair value of the Company’s Level 3 financial assets and liabilities that are measured at fair value on a recurring basis for the three months ended March 31, 2015 and 2014. As of March 31, 2015 and 2014, the Company did not have any net unrealized gains (losses) included in accumulated other comprehensive income on Level 3 financial assets. |
|
| | Trading | | | Investment | | | Total | | | | | |
Securities | Funds | | | | |
Beginning balance, January 1, 2015 | | $ | 3,188 | | | $ | 46,596 | | | $ | 49,784 | | | | | |
Total net gains (losses) (realized/unrealized) | | | | | | | | | | | | | | | | |
Included in earnings | | | (303 | ) | | | 384 | | | | 81 | | | | | |
Included in other comprehensive income | | | — | | | | — | | | | — | | | | | |
Purchases | | | 13,420 | | | | 750 | | | | 14,170 | | | | | |
Sales/Distributions | | | (13,420 | ) | | | (47 | ) | | | (13,467 | ) | | | | |
Transfers (out of) into Level 3 | | | (29 | ) | | | 3,245 | | | | 3,216 | | | | | |
Ending balance, March 31, 2015 | | $ | 2,856 | | | $ | 50,928 | | | $ | 53,784 | | | | | |
The amount of total gains or losses for the period | | $ | (303 | ) | | $ | 384 | | | $ | 81 | | | | | |
included in earnings attributable to the change in | | | | |
unrealized gains or losses relating to assets and | | | | |
liabilities still held at the reporting date | | | | |
|
|
| | Trading | | | Trading | | | Investment | | | Total | |
Securities | Securities Sold | Funds |
| not yet | |
| Purchased | |
Beginning balance, January 1, 2014 | | $ | 11,535 | | | $ | (1,499 | ) | | $ | 61,197 | | | $ | 71,233 | |
Total net gains (losses) (realized/unrealized) | | | | | | | | | | | | | | | | |
Included in earnings | | | (80 | ) | | | (122 | ) | | | 1,691 | | | | 1,489 | |
Included in other comprehensive income | | | — | | | | — | | | | — | | | | — | |
Purchases | | | 13,842 | | | | 6,043 | | | | 15,000 | | | | 34,885 | |
Sales/Distributions | | | (15,197 | ) | | | (4,422 | ) | | | (34 | ) | | | (19,653 | ) |
Transfers out of Level 3 | | | (6,216 | ) | | | — | | | | — | | | | (6,216 | ) |
Ending balance, March 31, 2014 | | $ | 3,884 | | | $ | — | | | $ | 77,854 | | | $ | 81,738 | |
The amount of total gains or losses for the period | | $ | (377 | ) | | $ | — | | | $ | 1,609 | | | $ | 1,232 | |
included in earnings attributable to the change in |
unrealized gains or losses relating to assets and |
liabilities still held at the reporting date |
|
There was one transfer out of Level 2 financial assets and into Level 3 and no transfers into Level 2 during the three months ended March 31, 2015. There were no transfers into, or out of Level 2 financial assets during the three months ended March 31, 2014. One transfer in each period was made out of Level 3 and into Level 1 during the three months ended March 31, 2015 and 2014, in both cases for an equity security that was previously a non-public equity security and during the applicable period became publicly traded. |
Gains and losses from Level 3 financial assets that are measured at fair value on a recurring basis, that are included in earnings for the three months ended March 31, 2015 and 2014, are reported in the following line descriptions on the Company’s consolidated statements of operations: |
|
| Three Months Ended | | | | | | | | | | |
| March 31, | | | | | | | | | | |
| 2015 | | | 2014 | | | | | | | | | | |
Total gains and losses included in earnings for the period: | | | | | | | | | | | | | | | | |
Institutional brokerage | $ | 1 | | | $ | (39 | ) | | | | | | | | | |
Net investment income | | 80 | | | | 1,528 | | | | | | | | | | |
Change in unrealized gains or losses relating to assets still | | | | | | | | | | | | | | | | |
held at the end of the respective period: | | | | | | | | | |
Institutional brokerage | $ | 1 | | | $ | (214 | ) | | | | | | | | | |
Net investment income | | 80 | | | | 1,446 | | | | | | | | | | |
|
Items Measured at Fair Value on a Non-Recurring Basis |
The Company also measures certain financial assets and liabilities and other assets at fair value on a non-recurring basis including items such as intangibles, fixed assets and estimated contingent consideration payable. Adjustments to the fair value of these assets and liabilities usually result from the application of lower-of-cost-or-market accounting or impairments of individual assets. Adjustments to the fair value of contingent consideration payable would result from differences between the underlying forecasted securities lending results and actual results (see Note 3). Due to the nature of these assets, unobservable inputs are used to value these assets and liabilities. In determining the fair value, the Company analyzes various financial, performance, and market factors to estimate the fair value, including where applicable, market activity. As a result, these assets and liabilities are classified within Level 3 of the fair value hierarchy. |
During the three months ended March 31, 2015, except for the impact of the scheduled partial payment of contingent consideration payable, there were no assets or liabilities measured at fair value on a non-recurring basis for which there was a change in carrying value. During the year ended December 31, 2014, there were no assets or liabilities measured at fair value on a non-recurring basis for which there was a change in carrying value. |
Financial Instruments Held for Investment—Designated as Trading |
As of March 31, 2015, and during the year ended December 31, 2014, the Company had certain investments in marketable equity securities held by other than its broker-dealer subsidiary that are classified as trading securities. In addition, as of March 31, 2015 and December 31, 2014, the Company had short positions in U.S. Treasury securities held by other than its broker-dealer subsidiary that are classified as trading securities. These investments are designated as trading based on the Company’s intent at the time of designation. In accordance with ASC 320, “Investments—Debt and Equity Securities” (“ASC 320”), these securities are carried at fair value with resulting realized and unrealized gains and losses reflected as net investment income (loss) in the consolidated statements of operations. In addition, pursuant to ASC 825, “Financial Instruments” (“ASC 825”), from time-to-time the Company may elect to account for non-public equity securities acquired by other than the Company’s broker-dealer subsidiary as part of its trading portfolio at fair value with resulting realized and unrealized gains and losses reflected as net investment income (loss) in the consolidated statements of operations. During the three months ended March 31, 2015, the Company did not make any such fair value elections. Net gains and losses on such trading securities as of the dates indicated were as follows: |
| | Three Months Ended | | | | | | | | | |
| | March 31, | | | | | | | | | |
| | 2015 | | | 2014 | | | | | | | | | |
Net gains recognized on trading securities | | $ | 2,691 | | | $ | 2,385 | | | | | | | | | |
Less: Net gains recognized on trading securities | | | (24 | ) | | | (237 | ) | | | | | | | | |
sold during the period | | | | | | | | |
Unrealized gains recognized on trading | | $ | 2,667 | | | $ | 2,148 | | | | | | | | | |
securities still held at the reporting date | | | | | | | | |
|
As part of the Company’s investing activities, during the three months ended March 31, 2015, the Company entered into two short sales, totaling $200,000 face value, of 4.625% U.S. Treasury securities. These securities mature in November 2016. During the three months ended March 31, 2014, as part of the Company’s investing activities, the Company entered into two short-sales of $100,000 face value each, 4.50% U.S. Treasury securities. These two securities which mature in November 2015 and February 2016, respectively, were settled in the fourth quarter of 2014. These positions are included in securities sold but not yet purchased on the Company’s consolidated balance sheets. Proceeds from open short-sales, as well as related margin requirements, are held in a collateral account and are included in due from brokers, dealers and clearing organizations in the Company’s consolidated balance sheets. Such amounts are not available for withdrawal and are subject to closure of the open short positions. During the three months ended March 31, 2015 and 2014, the Company incurred $3,197 and $1,677, respectively, of interest expense related to these transactions. The Company is obligated to fund the fixed-rate coupon interest on these securities while the short-positions are outstanding. |
Fair Value of the Investments Valued at NAV |
As of March 31, 2015 and December 31, 2014, the Company had $101,602 and $104,888, respectively, of investments that are valued at NAV. The following table presents information about the Company’s investments in hedge funds and private equity funds measured at fair value based on NAV at March 31, 2015 and December 31, 2014: |
|
|
| | March 31, 2015 | | | December 31, 2014 | |
| | Fair Value | | | Unfunded Commitment | | | Fair Value | | | Unfunded Commitment | |
Hedge funds: | | | | | | | | | | | | | | | | |
Fixed income/credit-related | | $ | 54,544 | | | $ | — | | | $ | 57,532 | | | $ | — | |
Multi-strategy | | | 36,684 | | | | — | | | | 37,890 | | | | — | |
Private equity funds | | | 10,374 | | | | 1,841 | | | | 9,466 | | | | 2,586 | |
Total | | $ | 101,602 | | | $ | 1,841 | | | $ | 104,888 | | | $ | 2,586 | |
|
Investments in hedge funds may be subject to lock-up restrictions or gates. A hedge fund lockup provision is a provision that provides that an investor may not make a withdrawal from the fund or may be subject to withdrawal fees. The purpose of a gate is to restrict the level of redemptions that an investor in a particular hedge fund can demand at any redemption date. All of the Company’s hedge fund investments have the ability to impose redemption gates. As of March 31, 2015, 50% of the fair value of the Company’s fund investments, or $50,674 of the hedge funds, was redeemable on either a monthly or quarterly basis with notice periods of 60 days or less, 26% of the fair value, or $26,570 of the hedge funds, was redeemable on a quarterly basis with notice periods of between 90 days and 180 days. In addition, 14% of the fair value, or $13,985 of the hedge funds was subject to lockup provisions 57% of which will expire during 2015. |
The Company’s fixed income and credit-related hedge fund investments include funds that primarily employ long-short or relative value strategies in order to benefit from investments in undervalued or overvalued securities that are primarily debt or credit related. The Company’s multi-strategy fund investments include funds that pursue a variety of fixed income, credit and asset-backed strategies to realize short and long term gains. Management of these hedge funds has the ability to overweight or underweight different strategies to best capitalize on current investment opportunities. |
The Company’s private equity fund investments include funds that pursue multiple strategies including direct lending, asset securitization and real estate development. These investments by the Company are generally not redeemable with the funds. The nature of these fund investments is that distributions are received through the liquidation of the underlying assets of the fund. At March 31, 2015 it was estimated that these funds will be liquidated in the next three years. |
Financial Instruments Held for Investment—Designated as Available-for-Sale |
From time-to-time, the Company may have investments in marketable equity securities held by other than the Company’s broker-dealer subsidiary that are classified as available-for-sale securities. These investments are designated as available-for-sale due to the Company’s intent at the time of designation to hold these securities for investment purposes over an extended period, however, they are available to be sold should economic conditions warrant such a transaction. In accordance with ASC 320, these securities are carried at fair value with resulting unrealized gains and losses reflected as other comprehensive income or loss. As of March 31, 2015, the Company did not have any marketable equity securities classified as available-for-sale. Gross unrealized gains and losses on available-for-sale securities as of December 31, 2014 were as follows: |
|
| | 31-Dec-14 | |
| | | | | | Unrealized | | | | | |
| | Cost Basis | | | Gains | | | Losses | | | Fair Value | |
Marketable equity securities | | $ | 100 | | | $ | 72 | | | $ | — | | | $ | 172 | |
|
The Company evaluates its portfolio of marketable equity securities for impairment as of each reporting date. For the securities with unrealized losses, the Company will review the underlying cause for the impairments, as well as the severity and duration of the impairments. If the impairment is determined to be other-than-temporary, the Company will recognize an other-than-temporary impairment loss in its consolidated statement of operations. The Company did not recognize any other-than-temporary impairment losses during the three months ended March 31, 2015 and 2014. As of March 31, 2014, the Company did not hold any marketable equity securities that were in an unrealized loss position. |
During the three months ended March 31, 2015, the Company sold its remaining marketable equity security classified as available-for-sale and received proceeds of $191 resulting in a gross gain of $91. There were no sales of marketable equity securities during the three months ended March 31, 2014. |
Other Comprehensive Income (Loss) |
The following tables set forth the changes in the Company’s accumulated other comprehensive income (loss) by component for the period indicated along with detail regarding reclassifications from other comprehensive income. All such reclassifications from other comprehensive income (loss) are included in net investment income in the Company’s consolidated statements of operations. |
|
|
| Three Months Ended March 31, | | | | | | | | | | |
| 2015 | | | 2014 | | | | | | | | | | |
Accumulated other comprehensive income, beginning balance | $ | 44 | | | $ | 34 | | | | | | | | | | |
Other comprehensive income before reclassifications | | — | | | | 19 | | | | | | | | | | |
Amounts reclassified from other comprehensive income | | (44 | ) | | | — | | | | | | | | | | |
Accumulated other comprehensive income, at period end | $ | — | | | $ | 53 | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | | | | | | | | | |
| 2015 | | | 2014 | | | | | | | | | | |
Reclassifications from other comprehensive income: | | | | | | | | | | | | | | | | |
Realized gains on sale of securities | $ | 44 | | | $ | — | | | | | | | | | | |
Other Investments, at Cost |
Other investments consisted of the following as of the dates indicated: |
|
| March 31, | | | December 31, | | | | | | | | | | |
2015 | 2014 | | | | | | | | | |
Non-public equity securities | $ | 7,000 | | | $ | 7,000 | | | | | | | | | | |
|
The Company evaluates its non-public equity securities, carried at cost, for impairment as of each reporting date. This evaluation includes consideration of the operating performance of the respective companies, their financial condition and their near-term and long-term prospects. Based on its evaluations of these investments, the Company recorded no impairment losses during the three months ended March 31, 2015 and 2014. |
During the three months ended March 31, 2015, there were no sales of investments carried at cost. During the three months ended March 31, 2014, the Company received $5,000 reflecting the full repayment at its maturity of a corporate debt investment that was carried at cost. |